Geron
Geron Corporation Alias
NASDAQ
United States of America
Telomerase inhibitor development
Cancer therapeutics
Biopharmaceutical research
Business Development
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

1 entries
DateDescription
2022 Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
+ Loaded when opened
2026-09-21 18:13 (Model: ggml-org/gpt-oss-20b )
↑